United States v. DPC (Tianjin) Co. Ltd. (C.D. Cal. 2005)
Case Details
- Case Name
- United States v. DPC (Tianjin) Co. Ltd. (C.D. Cal. 2005)
- Foreign Official
- Physicians and Laboratory Workers at Government-Owned Hospitals.
- Date of Conduct
-
1991 to 2001
- Nature of Business
- Provision of medical products and hospital services by DPC Co. Ltd., formerly Tianjin Depu Biotechnological and Medical Products Inc. (“Tianjin”), a Chinese subsidiary of Diagnostics Products Corporation (“DPC”). DPC, a U.S. corporation, is a worldwide provider of immunodiagnostic systems and reagents.
- Influence to be Obtained
- Payments were made, disguised as commissions, by senior employees of Tianjin in exchange for agreements that hospitals would retain Tianjin’s products and services.
- Enforcement
- In a company filing dated August 2005, DPC disclosed that it had agreed to pay approximately $4.8 million as part of a settlement with the SEC and DOJ, consisting of $2.0 million in fines and approximately $2.8 million in disgorgement of profits and interest. In addition, Tianjin pleaded guilty to violations of the FCPA, was issued a cease-and-desist order, and agreed to take certain actions, including engaging an independent monitor for its FCPA activities in China, to avert future violations.
- Amount of the Value
- $1.6 million.
- Amount of Business Related to Payment
- Not Stated.
- Total Sanction
- $ 2,000,000
- Reporting Requirements
- No
- Total Combined Monetary Sanction
- $ 4,788,622
Defendants
DPC (Tianjin) Co. Ltd.
- Citation
- United States v. Diagnostic Prods. Corp., No. 05-cr-482 (C.D. Cal. 2005).
- Other Statutory Provision
- None
- Disposition
- Plea Agreement
- Defendant Jurisdictional Basis
- Issuer
- Defendant's Citizenship
- United States
